AI-16 * HIF-1a INHIBITION BY RNA INTERFERENCE DELIVERED VIA A NOVEL MULTIFUNCTIONAL SURFACTANT ATTENUATES GLIOMA GROWTH IN AN INTRACRANIAL MOUSE MODEL
CONCLUSIONS: Treating glioblastoma with siRNA targeting HIF-1α in vivo can significantly reduce tumor growth and increase survival in an intracranial mouse model. Our novel siRNA carrier improves delivery of this treatment molecule. With further study this might be extended for use in human patients with malignant gliomas.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Jensen, R., Gillepsie, D. Tags: ANGIOGENESIS AND INVASION (CLINICAL AND/OR LABORATORY RESEARCH) Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Laboratory Medicine | Neurology | Polyethylene Glycol | Study